WDHD: International Inflammatory Bowel Disease Symposium in Mexico City - Jesus K. Yamamoto-Furusho M.D., Ph.D., M.Sc.

ewgn-vol22-issue2-FINAL

13 WORLD GASTROENTEROLOGY NEWS OCTOBER 2017 Editorial | Expert Point of View | WCOG at ACG 2017 | WDHD News | WGO & WGOF News | WGO Global Guidelines | Calendar of Events WDHD: International Inflammatory Bowel Disease Symposium in Mexico City Jesus K. Yamamoto-Furusho M.D., Ph.D., M.Sc. Founder and Director of the Inflammatory Bowel Disease Clinic, Department of Gastroenterology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City Professor of IBD Fellow at the National Autonomous University of Mexico (UNAM) President of the Pan American Crohn´s and Colitis Organisation (PANCCO) The International Symposium of Inflammatory Bowel Disease (IBD) was organized by Prof. Jesús K. Yamamoto-Furusho to celebrate the 10th anniversary of the IBD Clinic Foundation in the Department of Gastroenterology at the National In-stitute of Medical Sciences and Nutri-tion Salvador Zubirán (INCMNSZ) Hospital, as well as World Digestive Health Day (WDHD) focusing on IBD. It was held on 27 January, 2017 in Mexico City. Participating in the inaugural ses-sion were Dr. David Kershenobich, General Director of INCMNSZ, Dr. Luis Uscanga, Chief of the Depart-ment of Gastroenterology, Dr. Aurelio López, President of the Asociación Mexicana de Gastroenterología, and Prof. Jesús K. Yamamoto-Furusho, the founder and director of the IBD Clinic at INCMNSZ as well as Presi-dent of the Pan American Crohn´s and Colitis Organization (PANCCO). This symposium was a great suc-cess due to high-quality lectures and novel topics in IBD. There were 301 participants from across the coun-try in different fields related to IBD such as gastroenterologists, colorectal surgeons, radiologists, gastrointestinal endoscopists, psychologists, patholo-gists, nutritionists, social workers, rheumatologists, dermatologists and ophthalmologists. The IBD symposium consisted of two parts. The first focused on the medical community and had nine lectures with several topics about new aspects of the pathogenesis, biomark-ers in the monitoring of IBD pa-tients, scientific contributions of the IBD clinic at the INCMNSZ, novel endoscopic tools for the diagnosis and follow-up, outcomes of the anti-tumor necrosis factor alpha (anti- TNFa) therapy, the use of anti-TNFa biosimilars, new biological therapies and personalized medicine in patients with IBD. These lectures were pro-vided by international experts (Hillary Steinhart and Guillermo Veitia from Canada and Venezuela, respectively) and national professors (Gabriela Fonseca, Francisco Bosques, Rafael Barreto, Ylse Gutiérrez and Jesús K. Yamamoto-Furusho). The second part of the symposium was dedicated to patients with IBD and included approximately 100 attendees from the two main IBD patient associations named “Living with Crohn and CUCI” as well as the National Association of IBD. All lectures covered such topics as understanding IBD’s psychological and nutritional aspects. The partici-pants also related their own personal experiences. Finally, it is important to mention that the IBD Clinic at INCMNSZ was founded on January 2007 and its aims are focused on clinical, academic and research activities. Currently, this clinic provides more than 1,000 medical consultations per year, an advanced IBD fellowship course and participation in national and inter-national meetings. To date the clinic has published around 90 original and review scientific papers. The international IBD symposium was endorsed by the National Insti-tute of Medical Sciences and Nutri-tion Salvador Zubirán Hospital, the Asociación Mexicana de Gastroenter-ología and the Pan American Crohn´s There were 301 participants from across the country in different fields related to IBD such as gastroenterologists, colorectal surgeons, radiologists, gastrointestinal endoscopists, psychologists, pathologists, nutritionists, social workers, rheumatologists, dermatologists and ophthalmologists. IBD patient associations must work in collaboration with physicians to increase the communication about the knowledge of this disease and to reduce the fear of having IBD.


ewgn-vol22-issue2-FINAL
To see the actual publication please follow the link above